Evidence map›Paper›PMID 31718537›Full record

SynthesisBMC bioinformatics2019

An integrative methodology based on protein-protein interaction networks for identification and functional annotation of disease-relevant genes applied to channelopathies.

Milagros Marín, Francisco J Esteban, Hilario Ramírez-Rodrigo, Eduardo Ros, María José Sáez-Lara

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in BMC bioinformatics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Milagros MarínDepartment of Computer Architecture and Technology - CITIC, University of Granada, Granada, Spain.
Francisco J EstebanSystems Biology Unit, Department of Experimental Biology, University of Jaén, Jaén, Spain. festeban@ujaen.es.
Hilario Ramírez-RodrigoDepartment of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain.
Eduardo RosDepartment of Computer Architecture and Technology - CITIC, University of Granada, Granada, Spain.
María José Sáez-LaraDepartment of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain. mjsaez@ugr.es.ORCID http://orcid.org/0000-0001-7439-9817
Universidad de Granada · ESUniversidad de Jaén · ES

Funding

EU HBP SGA2, H2020-RIA 785907Junta de Andalucía (ES) BIO-302MEIC (Systems Medicine Excellence Network) SAF2015-70270-REDTMINECO-FEDER TIN2016-81041-R
6 · The paper itself

Abstract

backgroundBiologically data-driven networks have become powerful analytical tools that handle massive, heterogeneous datasets generated from biomedical fields. Protein-protein interaction networks can identify the most relevant structures directly tied to biological functions. Functional enrichments can then be performed based on these structural aspects of gene relationships for the study of channelopathies. Channelopathies refer to a complex group of disorders resulting from dysfunctional ion channels with distinct polygenic manifestations. This study presents a semi-automatic workflow using protein-protein interaction networks that can identify the most relevant genes and their biological processes and pathways in channelopathies to better understand their etiopathogenesis. In addition, the clinical manifestations that are strongly associated with these genes are also identified as the most characteristic in this complex group of diseases.

resultsIn particular, a set of nine representative disease-related genes was detected, these being the most significant genes in relation to their roles in channelopathies. In this way we attested the implication of some voltage-gated sodium (SCN1A, SCN2A, SCN4A, SCN4B, SCN5A, SCN9A) and potassium (KCNQ2, KCNH2) channels in cardiovascular diseases, epilepsies, febrile seizures, headache disorders, neuromuscular, neurodegenerative diseases or neurobehavioral manifestations. We also revealed the role of Ankyrin-G (ANK3) in the neurodegenerative and neurobehavioral disorders as well as the implication of these genes in other systems, such as the immunological or endocrine systems.

conclusionsThis research provides a systems biology approach to extract information from interaction networks of gene expression. We show how large-scale computational integration of heterogeneous datasets, PPI network analyses, functional databases and published literature may support the detection and assessment of possible potential therapeutic targets in the disease. Applying our workflow makes it feasible to spot the most relevant genes and unknown relationships in channelopathies and shows its potential as a first-step approach to identify both genes and functional interactions in clinical-knowledge scenarios of target diseases.

methodsAn initial gene pool is previously defined by searching general databases under a specific semantic framework. From the resulting interaction network, a subset of genes are identified as the most relevant through the workflow that includes centrality measures and other filtering and enrichment databases.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseMolecular Sequence AnnotationProtein Interaction MapsChannelopathiesDatabases, GeneticGene Regulatory NetworksHumansBehavioural diagnosisChannelopathiesGenetic diseasesGenotype-phenotype relationshipsProtein-protein interaction networksSystems medicineTranslational bioinformatics

Identifiers

PMID31718537
PMCPMC6849233
OpenAlexW2986428467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.